Order Entry
Puerto Rico
ContactUsLinkComponent
SensoLyte® 520 IDE Activity Assay Kit (Fluorimetric), AnaSpec
SensoLyte® 520 IDE Activity Assay Kit (Fluorimetric), AnaSpec
Catalog # 103010-678
Supplier:  Anaspec Inc
CAS Number:  
SensoLyte® 520 IDE Activity Assay Kit (Fluorimetric), AnaSpec
Catalog # 103010-678
Supplier:  Anaspec Inc
Supplier Number:  AS-72231
CAS Number:  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/us/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

Specifications

  • Size:
    100 Assays
  • Cat. No.:
    103010-678
  • Storage temperature:
    – 78 °C
  • Includes:
    The assays can be performed in a convenient 96-well microplate format, kit includes essential components and detailed protocol and references
  • Supplier no.:
    AS-72231

Specifications

About this item

Insulin degrading enzyme (IDE) is considered a physiological and pathological relevant enzyme

The SensoLyte® 520 IDE Activity Assay Kit can be used to detect enzyme activity in biological samples or in purified enzyme preparations. The unique FRET substrate was derived from an APP sequence designed to reduce cross reactivity with Neprilysin, ADAM10, TACE, BACE-1, and BACE-2. When active IDE cleaves the FRET substrate, it results in an increase of 5-FAM fluorescence, which is monitored at excitation/emission = 490 nm/520 nm. The long wavelength fluorescence of 5-FAM is also less interfered by the autofluorescence of components in biological samples and test compounds. This assay can detect as low as 0.8 ng/mL active IDE.

Growing evidence has indicated that IDE may be involved in the pathogenesis of Alzheimer’s disease and diabetes mellitus type 2.